130 related articles for article (PubMed ID: 11274802)
1. Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral.
Guo J; Ping Q; Chen Y
Int J Pharm; 2001 Mar; 216(1-2):17-21. PubMed ID: 11274802
[TBL] [Abstract][Full Text] [Related]
2. The absorption behavior of cyclosporin A lecithin vesicles in rat intestinal tissue.
Chen Y; Ping Q; Guo J; Lv W; Gao J
Int J Pharm; 2003 Aug; 261(1-2):21-6. PubMed ID: 12878392
[TBL] [Abstract][Full Text] [Related]
3. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.
Bistrup C; Nielsen FT; Jeppesen UE; Dieperink H
Nephrol Dial Transplant; 2001 Feb; 16(2):373-7. PubMed ID: 11158415
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion and microsphere formulations in rabbits.
Kim SJ; Choi HK; Suh SP; Lee YB
Eur J Pharm Sci; 2002 Jun; 15(5):497-502. PubMed ID: 12036726
[TBL] [Abstract][Full Text] [Related]
5. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies.
Colombo D; Egan CG
Int J Immunopathol Pharmacol; 2010; 23(4):1177-83. PubMed ID: 21244766
[TBL] [Abstract][Full Text] [Related]
7. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.
Guan P; Lu Y; Qi J; Niu M; Lian R; Hu F; Wu W
Int J Nanomedicine; 2011; 6():965-74. PubMed ID: 21720508
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Clin Pharmacol; 1997 Aug; 44(2):125-7. PubMed ID: 9278195
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
10. Sustained-release of Cyclosporin A pellets: preparation, in vitro release, pharmacokinetic studies and in vitro-in vivo correlation in beagle dogs.
Jiang D; Zeng J; Zhu Y; Zhou G; Deng W; Xu X; Yu J
Drug Dev Ind Pharm; 2016; 42(7):1174-82. PubMed ID: 26555803
[TBL] [Abstract][Full Text] [Related]
11. Solubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine A.
Guo J; Wu T; Ping Q; Chen Y; Shen J; Jiang G
Drug Deliv; 2005; 12(1):35-9. PubMed ID: 15801719
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in rats.
Koehler J; Kuehnel T; Kees F; Hoecherl K; Grobecker HF
Drug Metab Dispos; 2002 Jun; 30(6):658-62. PubMed ID: 12019192
[TBL] [Abstract][Full Text] [Related]
13. Oral bioavailability studies of niosomal formulations of Cyclosporine A in albino rabbits.
Ur Rehman M; Rasul A; Khan MI; Rasool M; Abbas G; Masood F; Nazir I; Iqbal M; Islam N; Hameed M; Shah PA
Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):313-319. PubMed ID: 34275856
[TBL] [Abstract][Full Text] [Related]
14. Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres.
Keohane K; Rosa M; Coulter IS; Griffin BT
Drug Dev Ind Pharm; 2016; 42(2):245-53. PubMed ID: 26083078
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
16. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.
Molpeceres J; Chacón M; Guzmán M; Berges L; del Rosario Aberturas M
Int J Pharm; 1999 Sep; 187(1):101-13. PubMed ID: 10502617
[TBL] [Abstract][Full Text] [Related]
17. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
[TBL] [Abstract][Full Text] [Related]
18. Studies on the cyclosporin A loaded stearic acid nanoparticles.
Zhang Q; Yie G; Li Y; Yang Q; Nagai T
Int J Pharm; 2000 May; 200(2):153-9. PubMed ID: 10867245
[TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.
Fischer JR; Harkin KR; Freeman LC
Vet Ther; 2002; 3(4):465-73. PubMed ID: 12584684
[TBL] [Abstract][Full Text] [Related]
20. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
